ReP USP - Resultado da busca

Artigo de periodico
miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps (2021)
Silveira, Mariana L. C.; Tamashiro, Edwin; Santos, Anemari R. D.; Martins, Ronaldo B.; Faria, Francesca M.; Silva, Lilian E. C. M.; Torrieri, Raul; Ruy, Patricia de C.; Silva Júnior, Wilson Araújo da; Arruda, Eurico; Anselmo-Lima, Wilma Terezinha; Valera, Fabiana Cardoso Pereira
Source: Rhinology Journal. Unidades: FMRP, SVOI
Subjects: DOENÇA CRÔNICA, MICRORNAS, PÓLIPOS NASAIS, SINUSITE, RINITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Mariana L. C. et al. miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps. Rhinology Journal, v. 59, n. 6, p. 567-576, 2021Tradução . . Disponível em: https://doi.org/10.4193/Rhin21.109. Acesso em: 12 jun. 2024.
APA
Silveira, M. L. C., Tamashiro, E., Santos, A. R. D., Martins, R. B., Faria, F. M., Silva, L. E. C. M., et al. (2021). miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps. Rhinology Journal, 59( 6), 567-576. doi:10.4193/Rhin21.109
NLM
Silveira MLC, Tamashiro E, Santos ARD, Martins RB, Faria FM, Silva LECM, Torrieri R, Ruy P de C, Silva Júnior WA da, Arruda E, Anselmo-Lima WT, Valera FCP. miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps [Internet]. Rhinology Journal. 2021 ; 59( 6): 567-576.[citado 2024 jun. 12 ] Available from: https://doi.org/10.4193/Rhin21.109
Vancouver
Silveira MLC, Tamashiro E, Santos ARD, Martins RB, Faria FM, Silva LECM, Torrieri R, Ruy P de C, Silva Júnior WA da, Arruda E, Anselmo-Lima WT, Valera FCP. miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps [Internet]. Rhinology Journal. 2021 ; 59( 6): 567-576.[citado 2024 jun. 12 ] Available from: https://doi.org/10.4193/Rhin21.109
Trabalho de evento-resumo
Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer (2021)
Souza, Luiz Paulo Chaves de; Costa, André Luiz Caliari ; Dutra, William Lautert; Melo, Camila Morais ; Albuquerque, Clarissa Gondim Picanço de; Vidotto, Thiago; Saggioro, Fabiano Pinto; Reis, Rodolfo Borges dos; Squire, Jeremy Andrew
Source: Resumos. Conference titles: Congresso Brasileiro de Genética = Brazilian Congress of Genetics. Unidades: SVOI, FMRP
Subjects: TRANSCRIÇÃO, NEOPLASIAS, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves de et al. Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer. 2021, Anais.. [Ribeirão Preto]: Sociedade Brasileira de Genética - SBG, 2021. Disponível em: https://www.sbg.org.br/anais. Acesso em: 12 jun. 2024.
APA
Souza, L. P. C. de, Costa, A. L. C., Dutra, W. L., Melo, C. M., Albuquerque, C. G. P. de, Vidotto, T., et al. (2021). Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer. In Resumos. [Ribeirão Preto]: Sociedade Brasileira de Genética - SBG. Recuperado de https://www.sbg.org.br/anais
NLM
Souza LPC de, Costa ALC, Dutra WL, Melo CM, Albuquerque CGP de, Vidotto T, Saggioro FP, Reis RB dos, Squire JA. Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer [Internet]. Resumos. 2021 ;[citado 2024 jun. 12 ] Available from: https://www.sbg.org.br/anais
Vancouver
Souza LPC de, Costa ALC, Dutra WL, Melo CM, Albuquerque CGP de, Vidotto T, Saggioro FP, Reis RB dos, Squire JA. Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer [Internet]. Resumos. 2021 ;[citado 2024 jun. 12 ] Available from: https://www.sbg.org.br/anais
Artigo de periodico
Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics (2021)
Souza, Luiz Paulo Chaves de; Melo, Camila Morais ; Saggioro, Fabiano Pinto ; Reis, Rodolfo Borges dos ; Squire, Jeremy Andrew
Source: Genes. Unidades: SVOI, FMRP
Subjects: NEOPLASIAS PROSTÁTICAS, IMUNOTERAPIA, ONCOGENES, GENES SUPRESSORES DE TUMOR, MUTAÇÃO GENÉTICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves de et al. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics. Genes, v. 12, n. 12, p. 1-18, 2021Tradução . . Disponível em: https://doi.org/10.3390/genes12121900. Acesso em: 12 jun. 2024.
APA
Souza, L. P. C. de, Melo, C. M., Saggioro, F. P., Reis, R. B. dos, & Squire, J. A. (2021). Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics. Genes, 12( 12), 1-18. doi:10.3390/genes12121900
NLM
Souza LPC de, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics [Internet]. Genes. 2021 ; 12( 12): 1-18.[citado 2024 jun. 12 ] Available from: https://doi.org/10.3390/genes12121900
Vancouver
Souza LPC de, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics [Internet]. Genes. 2021 ; 12( 12): 1-18.[citado 2024 jun. 12 ] Available from: https://doi.org/10.3390/genes12121900
Trabalho de evento-resumo periodico
ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer (2021)
Souza, Luiz Paulo Chaves; Costa, André Luiz Caliari ; Melo, Camila Morais ; Saggioro, Fabiano Pinto ; Squire, Jeremy Andrew
Source: Cancer Research. Conference titles: Proceedings of the American Association for Cancer Research Annual Meeting. Unidades: SVOI, FMRP
Subjects: PRÓSTATA, NEOPLASIAS, MUTAÇÃO GENÉTICA, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves et al. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer. Cancer Research. Philadelphia: , Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-1818. Acesso em: 12 jun. 2024. , 2021
APA
Souza, L. P. C., Costa, A. L. C., Melo, C. M., Saggioro, F. P., & Squire, J. A. (2021). ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer. Cancer Research. Philadelphia: , Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-1818
NLM
Souza LPC, Costa ALC, Melo CM, Saggioro FP, Squire JA. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer [Internet]. Cancer Research. 2021 ; 81[citado 2024 jun. 12 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-1818
Vancouver
Souza LPC, Costa ALC, Melo CM, Saggioro FP, Squire JA. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer [Internet]. Cancer Research. 2021 ; 81[citado 2024 jun. 12 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-1818
Artigo de periodico
Anti-TNF-therapy-induced leukocytoclastic vasculitis: a rare complication in IBD patients (2020)
Parra, Rogério Serafim ; Chebli, Julio; Chebli, Liliana; Lima Junior, Sérgio; Neto, Manoel; Medeiros, Terry; Faria, Francesca Maia; Feitosa, Marley Ribeiro; Féres, Omar ; Rocha, José Joaquim Ribeiro da
Source: The American Journal of Gastroenterology. Unidades: FMRP, SVOI
Subjects: VASCULITE, NECROSE, ENTEROPATIAS INFLAMATÓRIAS, DOENÇA DE CROHN
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, Rogério Serafim et al. Anti-TNF-therapy-induced leukocytoclastic vasculitis: a rare complication in IBD patients. The American Journal of Gastroenterology, p. S2, 2020Tradução . . Disponível em: https://doi.org/10.14309/01.ajg.0000722824.97430.19. Acesso em: 12 jun. 2024.
APA
Parra, R. S., Chebli, J., Chebli, L., Lima Junior, S., Neto, M., Medeiros, T., et al. (2020). Anti-TNF-therapy-induced leukocytoclastic vasculitis: a rare complication in IBD patients. The American Journal of Gastroenterology, S2. doi:10.14309/01.ajg.0000722824.97430.19
NLM
Parra RS, Chebli J, Chebli L, Lima Junior S, Neto M, Medeiros T, Faria FM, Feitosa MR, Féres O, Rocha JJR da. Anti-TNF-therapy-induced leukocytoclastic vasculitis: a rare complication in IBD patients [Internet]. The American Journal of Gastroenterology. 2020 ; S2.[citado 2024 jun. 12 ] Available from: https://doi.org/10.14309/01.ajg.0000722824.97430.19
Vancouver
Parra RS, Chebli J, Chebli L, Lima Junior S, Neto M, Medeiros T, Faria FM, Feitosa MR, Féres O, Rocha JJR da. Anti-TNF-therapy-induced leukocytoclastic vasculitis: a rare complication in IBD patients [Internet]. The American Journal of Gastroenterology. 2020 ; S2.[citado 2024 jun. 12 ] Available from: https://doi.org/10.14309/01.ajg.0000722824.97430.19
Artigo de periodico
A case of linear alopecia of the scalp (2020)
Santos, Cecília Anatriello dos; Westin, Andrezza Telles; Perecin, Fernanda André Martins Cruz; Simão, João Carlos Lopes; Faria, Francesca Maia; Frade, Marco Andrey Cipriani
Source: Skin Appendage Disorders. Unidades: SVOI, FMRP
Subjects: ALOPECIA, DOENÇAS DO CABELO, DERMATOPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Cecília Anatriello dos et al. A case of linear alopecia of the scalp. Skin Appendage Disorders, v. 6, n. 6, p. 389-392-392, 2020Tradução . . Disponível em: https://doi.org/10.1159/000510854. Acesso em: 12 jun. 2024.
APA
Santos, C. A. dos, Westin, A. T., Perecin, F. A. M. C., Simão, J. C. L., Faria, F. M., & Frade, M. A. C. (2020). A case of linear alopecia of the scalp. Skin Appendage Disorders, 6( 6), 389-392-392. doi:10.1159/000510854
NLM
Santos CA dos, Westin AT, Perecin FAMC, Simão JCL, Faria FM, Frade MAC. A case of linear alopecia of the scalp [Internet]. Skin Appendage Disorders. 2020 ; 6( 6): 389-392-392.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1159/000510854
Vancouver
Santos CA dos, Westin AT, Perecin FAMC, Simão JCL, Faria FM, Frade MAC. A case of linear alopecia of the scalp [Internet]. Skin Appendage Disorders. 2020 ; 6( 6): 389-392-392.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1159/000510854
Artigo de periodico
Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies (2020)
Oliveira, Vinicius Fernandes; Sousa, Graziella Ribeiro de ; Santos, Antonio Carlos dos ; Saggioro, Fabiano Pinto ; Machado, Hélio Rubens ; Oliveira, Ricardo Santos de ; Tone, Luiz Gonzaga ; Valera, Elvis Terci
Source: Child's Nervous System. Unidades: FMRP, SVOI
Subjects: NEOPLASIAS CEREBRAIS, EPIGÊNESE GENÉTICA, GLIOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Vinicius Fernandes et al. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies. Child's Nervous System, v. 37, n. 2, p. 375-382, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00381-020-04852-8. Acesso em: 12 jun. 2024.
APA
Oliveira, V. F., Sousa, G. R. de, Santos, A. C. dos, Saggioro, F. P., Machado, H. R., Oliveira, R. S. de, et al. (2020). Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies. Child's Nervous System, 37( 2), 375-382. doi:10.1007/s00381-020-04852-8
NLM
Oliveira VF, Sousa GR de, Santos AC dos, Saggioro FP, Machado HR, Oliveira RS de, Tone LG, Valera ET. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies [Internet]. Child's Nervous System. 2020 ; 37( 2): 375-382.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1007/s00381-020-04852-8
Vancouver
Oliveira VF, Sousa GR de, Santos AC dos, Saggioro FP, Machado HR, Oliveira RS de, Tone LG, Valera ET. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies [Internet]. Child's Nervous System. 2020 ; 37( 2): 375-382.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1007/s00381-020-04852-8
Artigo de periodico
microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma (2020)
Roberto, Gabriela Molinari; Lira, Régia Caroline ; Delsin, Lara Elis Alberici; Vieira, Gabriela Maciel ; Silva, Marcela de Oliveira; Hakime, Rodrigo Guedes; Yamashita, Mauricio Eiji de Almeida Santos; Engel, Edgard Eduard ; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga ; Annichini, María Sol Brassesco
Source: Pathology & Oncology Research. Unidades: SVOI, FMRP, FFCLRP
Subjects: OSTEOSSARCOMA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROBERTO, Gabriela Molinari et al. microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma. Pathology & Oncology Research, v. 26, n. 2, p. 877-883, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12253-019-00633-0. Acesso em: 12 jun. 2024.
APA
Roberto, G. M., Lira, R. C., Delsin, L. E. A., Vieira, G. M., Silva, M. de O., Hakime, R. G., et al. (2020). microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma. Pathology & Oncology Research, 26( 2), 877-883. doi:10.1007/s12253-019-00633-0
NLM
Roberto GM, Lira RC, Delsin LEA, Vieira GM, Silva M de O, Hakime RG, Yamashita ME de AS, Engel EE, Scrideli CA, Tone LG, Annichini MSB. microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma [Internet]. Pathology & Oncology Research. 2020 ; 26( 2): 877-883.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1007/s12253-019-00633-0
Vancouver
Roberto GM, Lira RC, Delsin LEA, Vieira GM, Silva M de O, Hakime RG, Yamashita ME de AS, Engel EE, Scrideli CA, Tone LG, Annichini MSB. microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma [Internet]. Pathology & Oncology Research. 2020 ; 26( 2): 877-883.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1007/s12253-019-00633-0
Artigo de periodico
mTOR pathway somatic variants and the molecular pathogenesis of hemimegalencephaly (2020)
Garcia, Camila Araújo Bernardino ; Carvalho, Simone da Costa e Silva; Yang, Xiaoxu; Ball, Laurel L.; George, Renee D.; James, Kiely N.; Stanley, Valentina; Breuss, Martin W; Thome, Úrsula; Santos, Marcelo Volpon ; Saggioro, Fabiano Pinto ; Serafini, Luciano Neder ; Silva Junior, Wilson Araújo da ; Gleeson, Joseph G.; Machado, Hélio Rubens
Source: Epilepsia Open. Unidades: FMRP, SVOI
Subjects: MALFORMAÇÕES, CÉREBRO, FENÓTIPOS, GENÓTIPOS, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Camila Araújo Bernardino et al. mTOR pathway somatic variants and the molecular pathogenesis of hemimegalencephaly. Epilepsia Open, v. 5, n. 1, p. 97-106, 2020Tradução . . Disponível em: https://doi.org/10.1002/epi4.12377. Acesso em: 12 jun. 2024.
APA
Garcia, C. A. B., Carvalho, S. da C. e S., Yang, X., Ball, L. L., George, R. D., James, K. N., et al. (2020). mTOR pathway somatic variants and the molecular pathogenesis of hemimegalencephaly. Epilepsia Open, 5( 1), 97-106. doi:10.1002/epi4.12377
NLM
Garcia CAB, Carvalho S da C e S, Yang X, Ball LL, George RD, James KN, Stanley V, Breuss MW, Thome Ú, Santos MV, Saggioro FP, Serafini LN, Silva Junior WA da, Gleeson JG, Machado HR. mTOR pathway somatic variants and the molecular pathogenesis of hemimegalencephaly [Internet]. Epilepsia Open. 2020 ; 5( 1): 97-106.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1002/epi4.12377
Vancouver
Garcia CAB, Carvalho S da C e S, Yang X, Ball LL, George RD, James KN, Stanley V, Breuss MW, Thome Ú, Santos MV, Saggioro FP, Serafini LN, Silva Junior WA da, Gleeson JG, Machado HR. mTOR pathway somatic variants and the molecular pathogenesis of hemimegalencephaly [Internet]. Epilepsia Open. 2020 ; 5( 1): 97-106.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1002/epi4.12377
Artigo de periodico
Value of adding the apparent diffusion coefficient to capsular contact for the prediction of extracapsular extension in prostate cancer (2020)
Silva Filho, Antonio Cordeiro da ; Rocha, Tamara Oliveira ; Elias Júnior, Jorge ; Barros, Marcus Vinicius de Castro ; Ribeiro-Silva, Alfredo ; Reis, Rodolfo Borges dos ; Muglia, Valdair Francisco
Source: Radiologia Brasileira. Unidades: FMRP, SVOI
Subjects: NEOPLASIAS PROSTÁTICAS, RESSONÂNCIA MAGNÉTICA, ESTADIAMENTO DE NEOPLASIAS, PRÓSTATA, ADENOCARCINOMA, IMAGEM POR RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA FILHO, Antonio Cordeiro da et al. Value of adding the apparent diffusion coefficient to capsular contact for the prediction of extracapsular extension in prostate cancer. Radiologia Brasileira, v. 53, n. 6, p. 381-389, 2020Tradução . . Disponível em: https://doi.org/10.1590/0100-3984.2019.0123. Acesso em: 12 jun. 2024.
APA
Silva Filho, A. C. da, Rocha, T. O., Elias Júnior, J., Barros, M. V. de C., Ribeiro-Silva, A., Reis, R. B. dos, & Muglia, V. F. (2020). Value of adding the apparent diffusion coefficient to capsular contact for the prediction of extracapsular extension in prostate cancer. Radiologia Brasileira, 53( 6), 381-389. doi:10.1590/0100-3984.2019.0123
NLM
Silva Filho AC da, Rocha TO, Elias Júnior J, Barros MV de C, Ribeiro-Silva A, Reis RB dos, Muglia VF. Value of adding the apparent diffusion coefficient to capsular contact for the prediction of extracapsular extension in prostate cancer [Internet]. Radiologia Brasileira. 2020 ; 53( 6): 381-389.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1590/0100-3984.2019.0123
Vancouver
Silva Filho AC da, Rocha TO, Elias Júnior J, Barros MV de C, Ribeiro-Silva A, Reis RB dos, Muglia VF. Value of adding the apparent diffusion coefficient to capsular contact for the prediction of extracapsular extension in prostate cancer [Internet]. Radiologia Brasileira. 2020 ; 53( 6): 381-389.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1590/0100-3984.2019.0123
Artigo de periodico
Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy (2020)
Hamamoto, Osmi; Tirapelli, Daniela Pretti da Cunha; Lizarte Neto, Fermino Sanches; Freitas-Lima, Priscila; Saggioro, Fabiano Pinto; Cirino, Mucio Luiz de Assis; Assirati Júnior, João Alberto; Neder, Luciano; Velasco, Tonicarlo Rodrigues; Sakamoto, Américo Ceiki; Carlotti Júnior, Carlos Gilberto
Source: Journal of Clinical Neuroscience. Unidades: FMRP, SVOI
Subjects: EPILEPSIA DO LOBO TEMPORAL, MICRORNAS, RECEPTORES DE GLUTAMATO, HIPOCAMPO, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAMAMOTO, Osmi et al. Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy. Journal of Clinical Neuroscience, v. 74, p. 180-186, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jocn.2020.02.024. Acesso em: 12 jun. 2024.
APA
Hamamoto, O., Tirapelli, D. P. da C., Lizarte Neto, F. S., Freitas-Lima, P., Saggioro, F. P., Cirino, M. L. de A., et al. (2020). Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy. Journal of Clinical Neuroscience, 74, 180-186. doi:10.1016/j.jocn.2020.02.024
NLM
Hamamoto O, Tirapelli DP da C, Lizarte Neto FS, Freitas-Lima P, Saggioro FP, Cirino ML de A, Assirati Júnior JA, Neder L, Velasco TR, Sakamoto AC, Carlotti Júnior CG. Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy [Internet]. Journal of Clinical Neuroscience. 2020 ; 74 180-186.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1016/j.jocn.2020.02.024
Vancouver
Hamamoto O, Tirapelli DP da C, Lizarte Neto FS, Freitas-Lima P, Saggioro FP, Cirino ML de A, Assirati Júnior JA, Neder L, Velasco TR, Sakamoto AC, Carlotti Júnior CG. Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy [Internet]. Journal of Clinical Neuroscience. 2020 ; 74 180-186.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1016/j.jocn.2020.02.024
Artigo de periodico
USP8 mutations and cell cycle regulation in corticotroph adenomas (2020)
Martins, Clarissa Silva ; Camargo, Renata Costa; Coeli-Lacchini, Fernanda Borchers; Saggioro, Fabiano Pinto ; Moreira, Ayrton Custódio; Castro, Margaret de
Source: Hormone and Metabolic Research. Unidades: FMRP, SVOI
Subjects: ADENOMA, HORMÔNIO ADRENOCORTICOTRÓFICO, CICLO CELULAR, PROTEÍNAS, EXONS, MUTAÇÃO, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Clarissa Silva et al. USP8 mutations and cell cycle regulation in corticotroph adenomas. Hormone and Metabolic Research, v. 52, n. 2, p. 117-123, 2020Tradução . . Disponível em: https://doi.org/10.1055/a-1089-7806. Acesso em: 12 jun. 2024.
APA
Martins, C. S., Camargo, R. C., Coeli-Lacchini, F. B., Saggioro, F. P., Moreira, A. C., & Castro, M. de. (2020). USP8 mutations and cell cycle regulation in corticotroph adenomas. Hormone and Metabolic Research, 52( 2), 117-123. doi:10.1055/a-1089-7806
NLM
Martins CS, Camargo RC, Coeli-Lacchini FB, Saggioro FP, Moreira AC, Castro M de. USP8 mutations and cell cycle regulation in corticotroph adenomas [Internet]. Hormone and Metabolic Research. 2020 ; 52( 2): 117-123.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1055/a-1089-7806
Vancouver
Martins CS, Camargo RC, Coeli-Lacchini FB, Saggioro FP, Moreira AC, Castro M de. USP8 mutations and cell cycle regulation in corticotroph adenomas [Internet]. Hormone and Metabolic Research. 2020 ; 52( 2): 117-123.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1055/a-1089-7806
Artigo de periodico
PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features (2019)
Albuquerque, Clarissa Gondim Picanço de; Vidotto, Thiago ; Pereira, C. S.; Saggioro, Fabiano Pinto ; Jamaspishvili, T.; Koti, M.; Berman, D. M.; Squire, Jeremy Andrew ; Reis, Rodolfo Borges dos
Source: Applied Cancer Research. Unidades: SVOI, FMRP
Subjects: NEOPLASIAS DOS GENITAIS MASCULINOS, ESCORE DO TESTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBUQUERQUE, Clarissa Gondim Picanço de et al. PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features. Applied Cancer Research, v. 39, 2019Tradução . . Disponível em: https://doi.org/10.1186/s41241-018-0071-y. Acesso em: 12 jun. 2024.
APA
Albuquerque, C. G. P. de, Vidotto, T., Pereira, C. S., Saggioro, F. P., Jamaspishvili, T., Koti, M., et al. (2019). PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features. Applied Cancer Research, 39. doi:10.1186/s41241-018-0071-y
NLM
Albuquerque CGP de, Vidotto T, Pereira CS, Saggioro FP, Jamaspishvili T, Koti M, Berman DM, Squire JA, Reis RB dos. PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features [Internet]. Applied Cancer Research. 2019 ; 39[citado 2024 jun. 12 ] Available from: https://doi.org/10.1186/s41241-018-0071-y
Vancouver
Albuquerque CGP de, Vidotto T, Pereira CS, Saggioro FP, Jamaspishvili T, Koti M, Berman DM, Squire JA, Reis RB dos. PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features [Internet]. Applied Cancer Research. 2019 ; 39[citado 2024 jun. 12 ] Available from: https://doi.org/10.1186/s41241-018-0071-y
Artigo de periodico
PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells (2019)
Vidotto, Thiago ; Saggioro, Fabiano Pinto ; Jamaspishvili, Tamara; Chesca, Deise Lúcia; Albuquerque, Clarissa Gondim Picanço de; Reis, Rodolfo Borges dos ; Graham, Charles H.; Berman, David M.; Siemens, D. Robert; Squire, Jeremy Andrew ; Koti, Madhuri
Source: The Prostate. Unidades: SVOI, FMRP
Subjects: PRÓSTATA, NEOPLASIAS, SISTEMA IMUNE, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDOTTO, Thiago et al. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, v. 79, n. 9, p. 969-979, 2019Tradução . . Disponível em: https://doi.org/10.1002/pros.23808. Acesso em: 12 jun. 2024.
APA
Vidotto, T., Saggioro, F. P., Jamaspishvili, T., Chesca, D. L., Albuquerque, C. G. P. de, Reis, R. B. dos, et al. (2019). PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, 79( 9), 969-979. doi:10.1002/pros.23808
NLM
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1002/pros.23808
Vancouver
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1002/pros.23808
Artigo de periodico
Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas (2019)
Leal, Letícia Ferro ; Cavagna, Rodrigo de Oliveira; Campanella, Nathalia Cristina; Mançano, Bruna; Almeida, Gisele Caravina; Matsushita, Marcus; Almeida Junior, Carlos Roberto; Saggioro, Fabiano Pinto ; Stavale, João Norberto; Malheiros, Suzana M. F.; Lima, Matheus; Hajj, Glaucia N. M.; Neder, Luciano ; Reis, Rui Manuel
Source: Journal of Neuropathology and Experimental Neurology. Unidades: SVOI, FMRP
Subjects: NEOPLASIAS CEREBRAIS, MEDULOBLASTOMA, MUTAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Letícia Ferro et al. Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas. Journal of Neuropathology and Experimental Neurology, v. 78, n. 9, p. 788-790, 2019Tradução . . Disponível em: https://doi.org/10.1093/jnen/nlz066. Acesso em: 12 jun. 2024.
APA
Leal, L. F., Cavagna, R. de O., Campanella, N. C., Mançano, B., Almeida, G. C., Matsushita, M., et al. (2019). Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas. Journal of Neuropathology and Experimental Neurology, 78( 9), 788-790. doi:10.1093/jnen/nlz066
NLM
Leal LF, Cavagna R de O, Campanella NC, Mançano B, Almeida GC, Matsushita M, Almeida Junior CR, Saggioro FP, Stavale JN, Malheiros SMF, Lima M, Hajj GNM, Neder L, Reis RM. Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas [Internet]. Journal of Neuropathology and Experimental Neurology. 2019 ; 78( 9): 788-790.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1093/jnen/nlz066
Vancouver
Leal LF, Cavagna R de O, Campanella NC, Mançano B, Almeida GC, Matsushita M, Almeida Junior CR, Saggioro FP, Stavale JN, Malheiros SMF, Lima M, Hajj GNM, Neder L, Reis RM. Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas [Internet]. Journal of Neuropathology and Experimental Neurology. 2019 ; 78( 9): 788-790.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1093/jnen/nlz066
Artigo de periodico
MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter (2019)
Darrigo Júnior, Luiz Guilherme ; Lira, Régia Caroline Peixoto ; Fedatto, Paola Fernanda ; Marco Antonio, David Santos ; Valera, Elvis Terci ; Aguiar, Simone; Yunes, Jose Andres ; Brandalise, Silvia Regina; Neder, Luciano ; Saggioro, Fabiano Pinto ; Becker, Aline Paixão ; Oliveira, Ricardo Santos de; Machado, Hélio Rubens; Panepucci, Rodrigo Alexandre ; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto
Source: Journal of Neuro-Oncology. Unidades: FMRP, SVOI
Subjects: NEUROFIBROMATOSES, ASTROCITOMA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DARRIGO JÚNIOR, Luiz Guilherme et al. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter. Journal of Neuro-Oncology, v. 141, n. 2, p. 373-382, 2019Tradução . . Disponível em: https://doi.org/10.1007/s11060-018-03042-6. Acesso em: 12 jun. 2024.
APA
Darrigo Júnior, L. G., Lira, R. C. P., Fedatto, P. F., Marco Antonio, D. S., Valera, E. T., Aguiar, S., et al. (2019). MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter. Journal of Neuro-Oncology, 141( 2), 373-382. doi:10.1007/s11060-018-03042-6
NLM
Darrigo Júnior LG, Lira RCP, Fedatto PF, Marco Antonio DS, Valera ET, Aguiar S, Yunes JA, Brandalise SR, Neder L, Saggioro FP, Becker AP, Oliveira RS de, Machado HR, Panepucci RA, Tone LG, Scrideli CA. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter [Internet]. Journal of Neuro-Oncology. 2019 ; 141( 2): 373-382.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1007/s11060-018-03042-6
Vancouver
Darrigo Júnior LG, Lira RCP, Fedatto PF, Marco Antonio DS, Valera ET, Aguiar S, Yunes JA, Brandalise SR, Neder L, Saggioro FP, Becker AP, Oliveira RS de, Machado HR, Panepucci RA, Tone LG, Scrideli CA. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter [Internet]. Journal of Neuro-Oncology. 2019 ; 141( 2): 373-382.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1007/s11060-018-03042-6
Artigo de periodico
Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma (2018)
Leal, Letícia Ferro; Evangelista, Adriane Feijó; Paula, Flávia Escremim de; Almeida, Gisele Caravina de; Carloni, Adriana C.; Saggioro, Fabiano Pinto; Stavale, João Norberto; Malheiros, Suzana Maria Fleury; Mançano, Bruna; Oliveira, Marco A. de; Luu, Betty; Neder, Luciano; Taylor, Michael D.; Reis, Rui Manuel
Source: Neuropathology. Unidades: SVOI, FMRP
Subjects: MEDULOBLASTOMA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Letícia Ferro et al. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma. Neuropathology, v. 38, n. 5, p. 475-483, 2018Tradução . . Disponível em: https://doi.org/10.1111/neup.12508. Acesso em: 12 jun. 2024.
APA
Leal, L. F., Evangelista, A. F., Paula, F. E. de, Almeida, G. C. de, Carloni, A. C., Saggioro, F. P., et al. (2018). Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma. Neuropathology, 38( 5), 475-483. doi:10.1111/neup.12508
NLM
Leal LF, Evangelista AF, Paula FE de, Almeida GC de, Carloni AC, Saggioro FP, Stavale JN, Malheiros SMF, Mançano B, Oliveira MA de, Luu B, Neder L, Taylor MD, Reis RM. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma [Internet]. Neuropathology. 2018 ; 38( 5): 475-483.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1111/neup.12508
Vancouver
Leal LF, Evangelista AF, Paula FE de, Almeida GC de, Carloni AC, Saggioro FP, Stavale JN, Malheiros SMF, Mançano B, Oliveira MA de, Luu B, Neder L, Taylor MD, Reis RM. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma [Internet]. Neuropathology. 2018 ; 38( 5): 475-483.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1111/neup.12508
Artigo de periodico
Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups (2018)
Salomão, Karina Bezerra; Cruzeiro, Gustavo Alencastro Veiga; Silva, Ricardo Bonfim; Geron, Lenisa; Ramalho, Fernando Silva; Saggioro, Fabiano Pinto; Neder, Luciano; Moreno, Daniel Antunes; Queiroz, Rosane Gomes de Paula; Aguiar, Simone dos Santos; Cardinalli, Izilda; Yunes, José Andres; Brandalise, Silvia Regina; Brassesco, Maria Sol; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Journal of Neuro-Oncology. Unidades: FMRP, SVOI, FFCLRP
Subjects: MEDULOBLASTOMA, GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALOMÃO, Karina Bezerra et al. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups. Journal of Neuro-Oncology, v. 139, n. 1, p. 33-42, 2018Tradução . . Disponível em: https://doi.org/10.1007/s11060-018-2845-1. Acesso em: 12 jun. 2024.
APA
Salomão, K. B., Cruzeiro, G. A. V., Silva, R. B., Geron, L., Ramalho, F. S., Saggioro, F. P., et al. (2018). Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups. Journal of Neuro-Oncology, 139( 1), 33-42. doi:10.1007/s11060-018-2845-1
NLM
Salomão KB, Cruzeiro GAV, Silva RB, Geron L, Ramalho FS, Saggioro FP, Neder L, Moreno DA, Queiroz RG de P, Aguiar S dos S, Cardinalli I, Yunes JA, Brandalise SR, Brassesco MS, Scrideli CA, Tone LG. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups [Internet]. Journal of Neuro-Oncology. 2018 ; 139( 1): 33-42.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1007/s11060-018-2845-1
Vancouver
Salomão KB, Cruzeiro GAV, Silva RB, Geron L, Ramalho FS, Saggioro FP, Neder L, Moreno DA, Queiroz RG de P, Aguiar S dos S, Cardinalli I, Yunes JA, Brandalise SR, Brassesco MS, Scrideli CA, Tone LG. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups [Internet]. Journal of Neuro-Oncology. 2018 ; 139( 1): 33-42.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1007/s11060-018-2845-1
Artigo de periodico
Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome (2018)
Josahkian, Juliana A.; Saggioro, Fabiano Pinto; Vidotto, Thiago; Ventura, Henrique Torres; Reis, Francisco José Cândido dos; Sousa, Christiâni Bisinoto de; Tiezzi, Daniel Guimarães; Andrade, Jurandyr Moreira de; Koti, Madhuri; Squire, Jeremy Andrew
Source: International Journal of Gynecological Cancer. Unidades: SVOI, FMRP
Subjects: BIOMARCADORES, ESTUDOS DE COORTES, IMUNOHISTOQUÍMICA, NEOPLASIAS OVARIANAS, FATORES DE RISCO, FATORES DE TRANSCRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOSAHKIAN, Juliana A. et al. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome. International Journal of Gynecological Cancer, v. 28, n. 3, p. 459-465, 2018Tradução . . Disponível em: https://doi.org/10.1097/igc.0000000000001193. Acesso em: 12 jun. 2024.
APA
Josahkian, J. A., Saggioro, F. P., Vidotto, T., Ventura, H. T., Reis, F. J. C. dos, Sousa, C. B. de, et al. (2018). Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome. International Journal of Gynecological Cancer, 28( 3), 459-465. doi:10.1097/igc.0000000000001193
NLM
Josahkian JA, Saggioro FP, Vidotto T, Ventura HT, Reis FJC dos, Sousa CB de, Tiezzi DG, Andrade JM de, Koti M, Squire JA. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome [Internet]. International Journal of Gynecological Cancer. 2018 ; 28( 3): 459-465.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1097/igc.0000000000001193
Vancouver
Josahkian JA, Saggioro FP, Vidotto T, Ventura HT, Reis FJC dos, Sousa CB de, Tiezzi DG, Andrade JM de, Koti M, Squire JA. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome [Internet]. International Journal of Gynecological Cancer. 2018 ; 28( 3): 459-465.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1097/igc.0000000000001193
Artigo de periodico
Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas (2018)
Jucá, Carlos Eduardo Barros; Colli, Leandro Machado; Martins, Clarissa Silva; Campanini, Marina Lanciotti; Paixão, Beatriz; Jucá, Renata Viana; Saggioro, Fabiano Pinto; Oliveira, Ricardo Santos de; Moreira, Ayrton Custódio; Machado, Hélio Rubens; Neder, Luciano; Antonini, Sonir Roberto Rauber; Castro, Margaret de
Source: Hormone and Metabolic Research. Unidades: FMRP, SVOI
Subjects: NEOPLASIAS CEREBRAIS, GLÂNDULA PITUITÁRIA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JUCÁ, Carlos Eduardo Barros et al. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas. Hormone and Metabolic Research, v. 50, n. 7, p. 575-581, 2018Tradução . . Disponível em: https://doi.org/10.1055/a-0593-5956. Acesso em: 12 jun. 2024.
APA
Jucá, C. E. B., Colli, L. M., Martins, C. S., Campanini, M. L., Paixão, B., Jucá, R. V., et al. (2018). Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas. Hormone and Metabolic Research, 50( 7), 575-581. doi:10.1055/a-0593-5956
NLM
Jucá CEB, Colli LM, Martins CS, Campanini ML, Paixão B, Jucá RV, Saggioro FP, Oliveira RS de, Moreira AC, Machado HR, Neder L, Antonini SRR, Castro M de. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas [Internet]. Hormone and Metabolic Research. 2018 ; 50( 7): 575-581.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1055/a-0593-5956
Vancouver
Jucá CEB, Colli LM, Martins CS, Campanini ML, Paixão B, Jucá RV, Saggioro FP, Oliveira RS de, Moreira AC, Machado HR, Neder L, Antonini SRR, Castro M de. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas [Internet]. Hormone and Metabolic Research. 2018 ; 50( 7): 575-581.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1055/a-0593-5956

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation